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Abstract
For  centuries,  the  therapeutic  benefits  of  grapes  and other  byproducts  have  been
empirically used for medical purposes such as bleeding, pain, inflammation, nausea,
diarrhea, gastroenteritis, or skin diseases. Moderated intake of the red wine improves
parameters as blood lipids, endothelial dysfunction, platelet aggregation, and other risk
factors  for  cardiovascular  disease.  However,  few  studies  have  been  explored  the
potential benefits from vine byproducts. Vine leaves, a waste product from the vine, are
also rich source of polyphenols and other therapeutic compounds. In this chapter, we
explored the therapeutic properties from vine leaf in different biological systems.
Keywords: polyphenols, organic viticulture, grapevine, natural products, live, heart,
kidney, brain
1. Introduction
The production of grapes is considered an economically important activity in many countries,
mainly related to the wine production [1]. Beyond their lucrative potential, grapes and their
byproducts show nutritional and functional properties [2–4]. Since centuries ago, grapes have
been  used  for  medical  purposes,  preventing  or  treating  diseases  as  nausea,  diarrhea,
gastroenteritis, or skin disorders [5]. More recently, the therapeutic effect of red wine has been
reported,  and  moderate  intake  has  been  related  to  improved  blood  lipid  parameters,
endothelial dysfunction, platelet aggregation, and other risk factors for cardiovascular disease
[6, 7]. Apart from the grape or wine, studies have been shown that grape byproducts such as
juice, or extracts from the skin, seed, or leaf also present therapeutic proprieties [8–12]. Grape
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leaves, for example, have been popularly used to stop bleeding, relieve pain, inflammation,
and diarrhea (Figure 1) [13, 14].
Figure 1. Popular use of vine leaf for health purpose.
Therapeutic proprieties by grapes, wine, or byproducts are mainly related to the polyphenolic
compounds [7, 15]. Leaves, which are a waste product from the grapevine, usually discarded
by grape farmers, are also rich source of polyphenols and other therapeutic compounds [16].
More recently, their therapeutic properties have been explored, mainly because grape juices
are rich in carbohydrates and wine is an alcoholic beverage, nonrecommended to diabetic or
alcoholics individuals, respectively.
2. Bioactive polyphenols in vine leaves
The grapevine (Vitis spp.) is cultivated across the world in different regions, mainly in
temperate climate with adequate rain, warm and dry summers, and mild winters [17]. Climate,
soil, conventional or organic cultivation method, and different cultivars are determinant to
phytochemical constitution of grapevines [18]. These phytochemical compounds include a
variety of bioactive organic acids (e.g., malic, oxalic, fumaric, ascorbic, citric, linoleic, and
tartaric acids), vitamin E, terpenes, tannins, carotenoids, and polyphenols that have been
highlighted for their beneficial effect on human health [19, 20]. The most important grape
polyphenols as flavanols (e.g., epicatechin and gallocatechin), flavonols (e.g., quercetin and
myricetin), anthocyanins (e.g., pelargonidin and cyanidin), and resveratrol are secondary
metabolites synthesized by plants and associated with growth, pigmentation, pollination,
environmental stress, and resistance against pathogens and predators [13, 17].
Polyphenols present biological activities, such as antioxidant, anti‐inflammatory, anticancer,
antimicrobial, cardioprotective, and antiaging effects [9, 14]. Polyphenols therapeutic proper‐
ties have been related to their chemical structure and ability to act as radical scavengers of the
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lipid peroxidation chain reactions, donating electrons, and neutralizing free radicals [21].
Moreover, they are chelators of metals as iron (Fe2+) and copper (Cu2+), preventing oxidation
caused by highly reactive hydroxyl radicals [21, 22]. They also inhibit the immune cell
recruitment (T lymphocytes and natural killer cells) and decrease the nuclear factor kappa B
(NFκB) expression [23, 24].
Species Viticulture
method
Preparation  Total phenolic
mg/g gallic acid
Phytochemicals detected  Reference
Vitis vinifera NI Ethanolic extract 216.0 ± 5.1 Total flavonoids [26]
Vitis vinifera NI Aqueous extract 149.93 ± 0.35 Total proanthocyanidin; total flavonoid [27]
Vitis vinifera NI Aqueous extract 146.3 ± 4.2 Anthocyanin: cyanidin‐3‐O‐glucoside >
peonidin‐3‐O‐glucoside
Flavonols: quercetin‐3‐O‐glucuronide
Caffeic acid derivatives: caftaric acid
[28]
Vitis vinifera NI Ethanolic extract 98.84 ± 9.26 NI [29]
Vitis labrusca Organic Aqueous extract 81.79 ± 2.68 Catechin; resveratrol [30]
Vitis vinifera NI Ethanolic extract 60.4 ± 0.4 Flavonols; quercetin‐3‐O‐glucuronide >
kaempherol‐3‐O‐glucoside
Anthocyanin: peonidin‐3‐glucoside >
cyanidin‐3‐glucoside
Hydroxycinnamic acid: trans‐caftaric
acid
[10]
Vitis labrusca Organic Ethanolic extract 20.2 ± 1.8 Catechin; resveratrol; quercetin; rutin;
kaempherol
[9]
Vitis labrusca Conventional Aqueous extract 19.83 ± 0.76 Catechin; resveratrol [30]
Vitis labrusca Conventional Ethanolic extract 19.0 ± 1.8 Catechin; resveratrol; quercetin; rutin;
kaempherol, naringin
[9]
Vitis vinifera NI Acetone/methanol
extract
Anthocyanins: peonidin 3‐glucoside >
malvidin > cyaniding 3‐glucoside;
flavonols: quercetin 3‐O‐β‐d‐glucuronide
> isoquercitrine quercetin 3‐O‐β‐d‐
glucoside phenolic acids
[16]
NI: not informed.
Table 1. Phenolic compounds from different vine leaf extracts.
A study comparing 10 grape cultivars grown in southern Georgia, USA, showed that the total
concentration of phenolic compounds was higher in seed (2178.8 mg/g gallic acid equivalent),
followed by skin (374.6 mg/g), and leaf (351.6 mg/g) [25], evidencing that the leaf is also an
important source of phenolic compounds. Although gallic acid was a dominant phenolic acid
in the vine leaf, other constituents may contribute to the beneficial properties of its extract.
Table 1 shows the phenolic contend in different extracts from V. vinifera and V. labrusca leaves.
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It reveals that ethanolic extracts show the highest extraction rate and the V. labrusca varietal
shows the highest total phenolic concentration. Optimal or prolonged low‐temperature
exposure decreases the phenolic contends in Vitis vinifera leaves from 526 g/g to 458 mg/g of
extract [31]. Antioxidant index, measured by trolox equivalent antioxidant capacity (TEAC)
assay, showed that, similarly to grape seeds, leaves present 10 times higher antioxidant activity
than grape juice or pulp [7]. Moreover, total phenolic levels in leaf are not affected by brining,
a method assumed to preserve vine leaves for future use in the Turkish cuisine [32]. Resveratrol,
a compound with therapeutic properties, accumulates in the surface of leaves at range of 40–
400 μg/g fresh weight in according to environmental conditions [33].
In addition to environmental influences, farming practices, as organic or conventional
viticulture, also interfere with the production of polyphenols [34]. In the organic viticulture,
grapevine grown in the absence of pesticides, chemicals, or genetic engineering modification,
and it is more vulnerable to external attacks from insets or microorganisms, which may
contribute to the higher production of phytochemicals, responsible for plant defenses [35]. A
study showed that organic vine leaf extract presents higher concentrations of resveratrol than
conventional vine extract, although total polyphenols were similar and catechin and quercetin
were lower [9, 30] (Table 1). Given the variability in the phenolic composition of the vine leaf,
the quantification of the phenolic constituents may estimate the quality and therapeutic
potential in vine leaves [16].
3. Effect of vine leaf extract on hepatic and gastrointestinal systems
Alcoholic and nonalcoholic liver diseases have been related to chronic exposition to risk factors
as alcohol, tobacco smoking, drugs, environmental pollutants, and irradiation. It is well known
that these risk factors promote excessive formation of oxygen and nitrogen reactive species
and may lead to oxidative damage in the liver [36]. Although clinical studies are scarce,
preclinical studies show that natural antioxidants from products as vine leaves prevent or
attenuate the severity of liver diseases induced by oxidative mechanisms. Animal studies have
explored some morphological and biochemistry changes by hepatotoxic substances and the
protective effect of vine leaf extracts. Aspartate aminotransferase (AST), alanine aminotrans‐
ferase (ALT), γ‐glutamyl transferase (GGT), and alkaline phosphatase (ALP) are some
biomarkers that predict liver function and explored in these studies. Aqueous extract from
Vitis coignetiae Pulliat leaves shows hepatoprotective effect after chronic oral administration in
an animal model of nonalcoholic steatohepatitis (NASH), evidenced by decreasing on AST and
ALP activity, confirmed by increasing in plasma antioxidants and delaying in the progression
of liver fibrosis [37] (Table 2). Similarly, alcoholic or butanolic extract of vine leaves (Vitis
vinifera) decreased AST and ALT activity after acute hepatotoxicity induced by carbon
tetrachloride (CCl4) in rats [26]. Vine leaves extract also decreased AST, ALT, ALP, and GGT
activity after chronic alcohol administration [29]. For both, CCl4 and alcohol‐induced hepato‐
toxicity models, vine leaves extract decreased biomarkers of serum oxidative stress as malon‐
dialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase
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(GPx) enzyme, as well decreased histopathological lesions [26, 29]. Preincubation with organic
and conventional vine leaf (Vitis labrusca) extracts also prevents both lipid and protein oxidative
damage in the rat liver after oxidative stress induced by hydrogen peroxide [39]. Moreover,
the organic vine leaves extract restored SOD and the conventional vine leaves extract restored
CAT activity, both decreased by hydrogen peroxide‐induced stress and related to different
phenolic contend in each extract [39] (Table 2). The liver of diabetic individual is also subject
to damage due to exposure to self‐oxidation of free glucose and deficiency of antioxidant
system [41]. Indeed, chronic oral administration of aqueous extract of organic grape leaves
(Vitis labrusca) reduced the AST activity in an experimental model of diabetes in rats [38]. The
synergistic effects of different polyphenols in the vine leaf extract reduced the oxidative stress,
preventing lipid and protein damage and increasing enzymatic and nonenzymatic antioxidant
defenses in the liver of diabetic rats, suggesting a promising therapeutic approach to hepatic
complications induced by diabetes [38].
Species  Culture method Treatment Condition Results Reference
Vitis labrusca Organic Aqueous extract
Orally
Diabetes (rats) ↓ Lipid peroxidation
↓ Protein damage
↑ Nonenzymatic antioxidant
defenses
↑ SOD activity
↓ CAT activity
↓ AST
[38]
Vitis labrusca
Vitis labrusca
Organic
Conventional
Aqueous extract
preincubation
H2O2‐induced stress(in vitro)
↓ Lipid peroxidation
↓ Protein damage
↑ SOD activity
↓ Lipid peroxidation
↓ Protein damage
↑ CAT activity
[39]
Vitis vinifera NI n‐BuOH extract
Orally
Cirrhosis (rats) ↓ Lipid peroxidation
↑ GSH content
↓ Histopathological injury
↓ AST, ALT
[26]
Vitis vinifera NI Ethanolic extract
Orally
Alcohol induced
oxicity
(rats)
↓ AST, ALT, ALP, GGT
↓ Lipid peroxidation
↓ Hydroperoxides
↑ Vitamin E
↑ Vitamin C
↑ GSH
↑ SOD activity
↑ CAT activity
↑ GPx activity
↑ GST activity
[29]
Vitis coignetiae  NI Aqueous extract
Orally
Nonalcoholic steatohepatitis
(rats)
↓ ALT
↓ Fibrosis area
↓ MPO activity
↓ Mitochondrial ROS
↓ NFκB expression
[40]
Vitis coignetiae  NI Aqueous extract
Orally
Nonalcoholic steatohepatitis
(rats)
↓ AST and ALP
↓ CYP2E1 induction
↓ Fibrosis
[37]
NI: not informed; AST: aspartate aminotransferase; ALT: alanine aminotransferase; GGT: γ‐glutamyl transferase; ALP:
alkaline phosphatase; SOD: superoxide dismutase, CAT: catalase; GPx: glutathione peroxidase; GSH: reduced
glutathione; GST: glutathione‐S‐transferase; ROS: reactive oxygen species; MPO: myeloperoxidase; NFκB; factor
nuclear kappa B.
Table 2. Hepatoprotective effects of vine leaf.
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Vine leaves extract (Vitis coignetiae Pulliat) decreases the leakage of biliary enzymes and
attenuates liver fibrosis after 3 weeks of treatment in a model of nonalcoholic steatohepatitis
in rats [40]. Improving on hepatic fibroses or suppression of its progression by the extract was
associated to increasing on plasma antioxidant activity, decreasing on reactive species and
NFκB activity, a key pathway linking oxidative stress and inflammation [40]. Vine leaves
extract from Vitis vinifera preserved the integrity of the membrane of hepatocytes in CCl4‐
intoxicated rats, evidenced by the reduction in plasma levels of AST, ALT, and GGT [27].
Additionally, the extract reduced the concentration of bilirubin, lipoproteins, lipid oxidation
and, in parallel, preserved histological injuries of the liver [27].
Among the gastrointestinal diseases, the prevalence and incidence of gastritis, peptic ulcers,
and inflammatory bowel disease have increased in recent years, associated to the consumption
of processed foods and lifestyle [42]. The activation of inflammatory pathways is the common
pathological mechanism of these diseases and initiates by the activation of NFκB, which is
related with transcriptional control of multiple proinflammatory mediators as IL‐1β, TNF‐α,
and IL‐8 in the gastrointestinal tissue [43].
In this context, the biological activity of the aqueous extract of vine leaves (Vitis vinifera) was
assessed in vitro in a model of gastric inflammation (human gastric and intestinal epithelial
cell) [28]. Vine leaf extracts impaired the NFκB pathway and, consequently, reduced the TNF‐
α and IL‐8 secretion and expression by gastric epithelial cells. The anti‐inflammatory effect of
the extract decreased significantly after simulation of intestinal digestion, explained by the
poor stability and high rate of degradation of anthocyanins and flavonoids present in the
aqueous extract of vine leaves in an alkaline pH [28].
4. Effect of vine leaf extract on the cardiovascular system
Cardiovascular diseases are the most common causes of morbidity and mortality worldwide,
currently responsible for over 17 million deaths, with growth forecast to 23.6 million per year
to 2030 [44]. Hypertension, dyslipidemia, obesity, and smoking are considered the main
cardiovascular risk factors [45]. These factors adversely affect the vascular endothelium,
reducing the availability of nitric oxide, facilitating the deposition of oxidized LDL cholesterol
by activating oxidative and inflammatory cascades leading to atherosclerosis, endothelial
dysfunction, and cardiovascular damage [46].
Studies suggest that consumption of grape polyphenols and its derivatives is associated with
reduction in cardiovascular risk related to their antioxidant, anti‐inflammatory, and antith‐
rombotic properties [6]. It is well known that there is a correlation between moderate con‐
sumption of red wine and the lowest risk of death associated with heart disease [47, 48]. Indeed,
the daily consumption of low to moderate doses of wine reduces by half the risk of death
compared to individuals who did not drink wine [49]. Aqueous extract of grape leaves has
been tested in rodents and evidenced also an antioxidant effect, decreasing lipid and protein
damage, as well increasing SOD and CAT activity in a heart homogenates injured by H2O2 in
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rats [39]. These antioxidant effects were more significant compared to those extracts prepared
from organic grape leaves [39] (Table 3).
Specie Viticulture
method
Treatment Condition Target tissue Results Reference
Vitis
labrusca
Organic and
conventional
Aqueous extract
Preincubation
H2O2‐inducedstress
(in vitro)
Heart ↓ Lipid peroxidation
↓ Damage protein
↑ CAT activity
[39]
Vitis
vinifera
NI Aqueous extract
Orally
Diabetic (rats) Heart ↑ GSH content [50]
Vitis
vinifera
NI Ethanolic extract
Orally
Alcohol‐
induced
toxicity
(rats)
Kidney ↓ TBARS
↓ Hydroperoxides
↑ Vitamin E and
vitamin C
↑ GSH
↑ SOD activity
↑ CAT activity
↑ GPx activity
↑ GST activity
[29]
Vitis
labrusca
Organic Aqueous extract
preincubation
H2O2‐induced
stress
(in vitro)
Kidney ↓ Lipid peroxidation
↓ Damage protein
↑ SOD activity
[39]
Vitis
vinifera
NI Aqueous extract
Orally
Toxicity‐
induced by
CCl4 (rats)
Kidney ↓ Creatinine, uric acid,
and calcium levels
↓ MDA
↑ NP‐SH
[27]
Vitis
labrusca
Organic and
conventional
Aqueous extract
preincubation
H2O2‐induced
stress
(in vitro)
Cerebral
cortex, 
cerebellum
and 
hippocampus
↓ Lipid peroxidation:
cerebellum, hippocampus
↓ Damage protein: cerebral
cortex, cerebellum,
hippocampus
↓ Lipid peroxidation:
cerebellum
↓ Damage protein: cerebral
cortex
[9]
Vitis
labrusca
Organic Aqueous extract
pretreatment
(intraperitoneally)
CCl4‐inducedstress
(in rats)
Cerebral
cortex, 
cerebellum
and 
hippocampus
↓ Damage protein: cerebral
cortex, cerebellum,
hippocampus
↓ SOD activity: cerebral
cortex, hippocampus
↑ SOD activity: cerebellum
↑ SOD/CAT ratio: cerebral
cortex, cerebellum
[30]
NI: not informed; CCl4: carbon tetrachloride; MDA: malondialdehyde; NP‐SH: nonprotein sulfhydryl; SOD: superoxide
dismutase; CAT: catalase; GPx: glutathione peroxidase; GSH: reduced glutathione; GST: glutathione‐S‐transferase.
Table 3. Therapeutic effects of vine leaf in different tissues.
Aqueous extract of grape leaves also presents an in vivo antioxidant effect, increasing the GHS
levels in the heart of streptozotocin‐induced diabetic rats, at doses of 500 mg/kg [50], although
it did not change MDA levels (Table 3).
Vine leaves are rich in polyphenols such as flavonoids and anthocyanins (Table 1). Beside
antioxidant activities, polyphenols inhibit pro‐oxidant enzymes (e.g., xanthine oxidase,
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NADPH oxidase, lipoxygenases), chelate transient metals, interact with some ion channels,
reduce platelet aggregation and leukocyte adhesion, and promote vasodilatation, decreasing
the resistance to blood flow [51, 52]. Anthocyanins are also responsible for increasing in the
strength and vascular permeability, as well as the inhibition of platelet aggregation [53]. Studies
suggest that they promote vasorelaxation by increasing nitric oxide levels and by inhibiting
the action of phosphodiesterase‐5 enzyme, which metabolizes the cyclic guanosine mono‐
phosphate (cGMP), an important vasodilator, reducing the risk of cardiovascular disease [54].
Anti‐inflammatory properties from flavonoids and other grapevine constituents also contrib‐
ute to the cardioprotective mechanism against injury caused by ischemia‐reperfusion [51, 52].
Flavonoids inhibit phospholipase A2 and cyclooxygenase enzymes, decreasing prostaglandins
synthesis and, indirectly, all inflammatory cascade [55]. Studies show that flavonoids inhibit
the TNF‐α, IL1‐β, and interferon‐γ synthesis [51]. All these mechanisms contribute to LDL
cholesterol reduction and increasing on HDL cholesterol, useful to protect against cardiovas‐
cular disease [56].
A commercial standardized red vine leaf aqueous extract (Antistax®, Boehringer Ingelheim
Pharma GmbH & Co, Ingelheim am Rhein, Germany) from Vitis vinifera Folium is available for
chronic venous insufficiency, improving the cutaneous microcirculation and oxygen supply in
humans [57]. A randomized, double blind study showed that this vine leaf extract decreased
the lower leg edema and circumference in chronic venous insufficiency patients [58]. Addi‐
tionally, the vine leaf extract was investigated in women in long‐term hormone replacement
therapy with phlebopathy of the lower limbs [59]. After 3 months, leaf extract treatment
decreased the calf and ankle circumference, besides the diameter of the great saphenous vein
(GSV), relieving venous symptoms, and improving the quality of life of users [59]. Regulation
of blood flow by vine left extract has been positively associated to NO (nitric oxide) synthesis
by endothelial and red blood cells, adding to its antioxidant properties [60].
5. Effect of vine leaf extract on the renal system
Diseases that affect the renal system are related to progressive and irreversible loss of kidney
function, and inability of the kidney to adequately clean waste products from the blood. This
condition is characterized by a reduction in glomerular filtration rate, decreased urine output,
proteinuria and microalbunuria, common in diabetes, and hypertensive patients [61, 62].
Oxidative stress is considered an important pathogenic mechanism in renal diseases [61]. In
diabetic individuals, particularly, high levels of final advanced glycation end products (AGEs),
reactive species, and oxidative stress promote protein oxidation, DNA damage, and apoptosis
[62, 63]. Glomerular hypertrophy and tubulointerstitial fibrosis in the kidney in diabetic
individuals may progress to nephropathy [63]. Buffering the generation of oxidative pathway
may represent a nephroprotective effect against oxidative damage by diabetes [62].
In this context, unpublished results from our group (Figure 2) showed the beneficial effects of
an organic aqueous vine leaves extract on the kidney of diabetes rats, agreeing with the results
Grape and Wine Biotechnology132
from others [62]. In our experimental protocol, nondiabetic (C) and streptozotocin‐induced
diabetic (D) rats were daily administered with 50, 100, and 200 mg/kg of an organic vine leaf
extract, by oral gavage, for 30 days (design details showed at [38]). The kidney was collected
for analysis of oxidative stress parameters and the blood, for urea and creatinine determina‐
tion. A two‐away ANOVA showed that diabetes significantly increased protein oxidation
(carbonyl), and SOD activity (P < 0.05) and decreased the total sulfhydryl levels (P < 0.001) in
the kidney of diabetic rats. All three doses prevented the protein carbonylation (P < 0.05)
increased by diabetes, but only the dose of 50 mg/kg restored sulfhydryl levels (P < 0.05) and
decreased the SOD activity (P < 0.05) (Figure 2).
Figure 2. Effect of different doses (50, 100, and 200 mg/kg) of an organic aqueous vine leaf extract in the (A) carbonyl
levels, (B) total sulfhydryl levels, and (C) SOD activity in the kidney of nondiabetic (C) and diabetic (D) rats. Values
were represented as mean ± standard error; n = 10/group; ANOVA two‐way + Bonferroni. (#) Different from C0 group,
P < 0.05; (*) different from D0 group, P < 0.001.
We also showed that diabetes increased the relative kidney weight (P < 0.001) and urea (P <
0.05) and decreased creatinine levels (Table 4). The organic vine leaf extract did not change
kidney weight, but the dose of 50 mg/kg significantly decreased urea levels in diabetic rats.
Moreover, the organic extract decreased creatinine at doses of 50 and 100 mg/kg in diabetic
rats and at dose of 50 mg/kg in nondiabetic rats.
The nephroprotective effect of our vine leaf extract is related to its ability to inhibit in vivo
oxidative stress. Our results replayed in vitro assays that showed that the organic and conven‐
tional vine leaf extracts prevent both lipids and proteins oxidative damages in the kidney after
hydrogen peroxide or alcohol‐induced stress [29, 39]. Polyphenols are the main antioxidants
from vine leaf, since these compounds undergo redox reactions and hydrogen atoms transfer
from the phenolic hydroxyl group to the free radicals, stabilizing them [29, 64]. Bioactive
phytochemicals in our extract showed a remarkable antioxidant activity as evidenced by the
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reduction of protein oxidation and increase in nonenzymatic antioxidants in the renal tissue
of diabetic rats. Resveratrol, one of these bioactive compounds, restores the nonenzymatic
levels of antioxidants in the kidney of diabetic rats by reducing the availability of reactive
species and improving antioxidant status in this tissue [65]. Indeed, flavonoids increase the
expression of enzyme γ‐glutamylcysteine synthetase, a rate‐limiting enzyme in the synthesis
of glutathione, a potent antioxidant [66].
Groups Kidney weight (g) Urea (mg/dl) Creatinine (mg/dl)
C0 0.32 ± 0.03 31.01 ± 12.58 0.29 ± 0.04
C50 0.31 ± 0.03 29.20 ± 3.70 0.25 ± 0.03**
C100 0.31 ± 0.03 28.05 ± 7.59 0.28 ± 0.03
C200 0.33 ± 0.08 27.80 ± 4.08 0.28 ± 0.07
D0 0.53 ± 0.08* 77.03 ± 25.52* 0.29 ± 0.08
D50 0.52 ± 0.07* 40.71 ± 16.78# 0.20 ± 0.03*#
D100 0.52 ± 0.04* 56.02 ± 16.39 0.25 ± 0.07#
D200 0.50 ± 0.06* 59.80 ± 22.32 0.31 ± 0.09
P <0.001 <0.05 <0.05
Values are represented as mean ± standard deviation, n = 10/group; ANOVA two‐way + Bonferroni; (*) different from C
groups; (**) different from C0 group, (#) different from D0 group.
Table 4. Relative weights of kidney (g/% body weight), as well as urea and creatinine levels, after 30 days of daily oral
administration from an organic aqueous vine (Vitis labrusca, L.) leaf extract, in different doses (50, 100, or 200 mg/kg), in
diabetic (D) and nondiabetic (C) rats.
Regarding the antioxidant enzymes, we found that only the dose of 50 mg/kg prevented the
increasing on SOD activity in the kidney by the chronic hyperglycemia. Because SOD catalyzes
the dismutation of superoxide to H2O2 and water, we may infer that this was the main reactive
species produced in this tissue in our diabetic rats, prevented by polyphenols present in the
organic vine leaf extract [38]. We do not discard that diverse effect would be found after chronic
treatment with conventional vine leaf extract, since a study showed that only the organic
extract from vine leaf (Vitis labrusca) restored SOD activity after in vitro alcohol‐induced stress
in the kidney of rats [39].
Lower urea and creatinine in diabetic rats treated with vine leaf extract at the dose of 50 and
100 mg/kg suggested a dose‐related nephroprotective effect and consequently, improving on
renal function. These results agree with another study that showed that polyphenols extracts
from Hibiscus sabdariffa improved renal function in an experimental model of diabetes [67].
Resveratrol also decreased creatinine and urea levels, protecting against kidney damage
caused by chronic hyperglycemia [65]. In nondiabetic rats, our extract decreased creatinine
levels at dose of 50 mg/kg, suggesting an improvement on renal function by hemodynamic
mechanisms, already evidenced by regulation of blood flow from poliphenols [57]. Indeed,
acute aqueous extracts of Vitis indica leaves increased the urine volume, sodium and potassium
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chloride excretion in rats [68]. Moreover, the pretreatment with epicatechin in rats exposed to
an animal model of nephrolithiasis increased creatinine excretion and urine volume, reducing
renal calcium and preventing papillary renal tissue from subepithelial calcification [69].
Pretreatment with vine leaf (Vitis vinifera) extract also restored the renal function, evidenced
by decreasing on creatinine, urea, uric acid, and calcium plasma levels, associate to lower
histopathologic injuries (Table 3) [27]. In addition, all these parameters were related to lower
lipid oxidation and restoring on nonenzymatic antioxidant defenses in the kidney. Such
nefroprotetive effects were attributed to the antioxidant properties of proanthocyanidins and
other flavonoids present in vine leaf [27].
6. Effect of vine leaf extracts on the central nervous system
The brain is susceptible to the oxidative damage and shows high oxygen consumption rate
and abundant lipid content. Indeed, evidence shows that oxidative stress and inflammation
are associated with Parkinson, Alzheimer, and other neurodegenerative diseases [70–72].
Bioactive compounds as flavonols, flavan‐3‐ols, anthocyanins, phenolic acids, or resveratrol,
in red wine and other grapevine byproducts have been extensively studied by their central
effect. Conventional and organic vines leaf extracts decrease lipid and protein oxidative
damage induced by hydrogen peroxide (H2O2) in the rat brain, reestablishing the SOD and
CAT activity [9]. The same neuroprotective effect was found after treatment with both
conventional and organic vines leaf extracts in the cortex, hippocampus, and cerebellum after
carbon tetrachloride‐induced stress in rats [30].
Although poor central bioavailability, resveratrol is effective for the treatment of aging‐related
learning and memory deficits [73]. A recent study showed that oral resveratrol (20 and 40 mg/
kg) ameliorated learning and memory impairment and prevented memory extinction in mice
in an in vivo animal model of Alzheimer disease [74]. Agreeing with these results, resveratrol
also improve learning and memory in old mice, related to increasing on CREB (cAMP response
element‐binding) and BDNF (brain‐derived neurotrophic factor) proteins in the hippocam‐
pus [75]. Adding to these neurochemical mechanisms, the beneficial effect of resveratrol have
been related to its anti‐inflammatory and antioxidant properties in different brain areas as in
the hippocampus, and frontal cortex of diabetic and nondiabetic rats [76]. Natural products,
rich in anthocyanin, as purple sweet potato extracts also exhibit antioxidant properties and
memory enhancing effects in rats [77].
Methanolic Vitis amurensis leaf extract (25–100 mg/kg, oral gavage) prevented oxidative stress
after cerebral ischemic in rats indicated by increasing on GSH and decreasing on lipid
peroxidation, beyond inhibition of cyclooxygenase‐2, and phosphorylated mitogen‐activated
protein kinases (MAPKs) [78]. Moreover, that extract inhibited the glutamate‐induced
neuronal death in vitro, and changed the apoptosis‐related proteins, suggesting that the
neuroprotective effect of this extract is related to its antioxidant, anti‐inflammatory, and anti‐
excitotoxic properties, preventing the neurodegeneration in stroke [78]. Glutamate‐induced
neural cytotoxicity in vitro was prevented by a V. vinifera seed extract [79]. Grape seed extract
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also inhibited DNA damage in the CA1 region of gerbil hippocampus after transient forebrain
ischemia, evidencing a neuroprotective effect [80].
7. Conclusion
For centuries, the therapeutic benefits of grapevines and other byproducts have been empiri‐
cally explored. Recently, it has grown the interest in the health benefits from vine leaves. Leaves
remain a waste product from many vine farming, although they show 10 times higher
antioxidant activity than grape juice or pulp. Vine leaf extracts, for medical use, or freshly/
cooked, for eating as a supplement, are devoid of alcohol (as wine) or sugar (as juice) providing
an additional advantage from other vine byproducts. Here, we showed the effect of vine leaf
extract in different tissues and point the needed of increase the researchers in the area to explore
clinical use of this natural product.
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